WHAT THE STUDY ACTUALLY SAYS

Does rosemary oil regrow hair? One small trial, drawn with minoxidil, is the whole case

A single randomised trial found rosemary oil and 2% minoxidil produced statistically indistinguishable hair counts at six months. It is the strongest evidence rosemary has — and it is thin.

The claim that rosemary oil regrows hair rests almost entirely on one randomised trial, in which rosemary oil and 2% minoxidil produced hair counts that could not be told apart after six months [s1]. That is a genuine result and the best evidence the ingredient has — but it is a single small study against a low-dose comparator, not the settled science the trend built on it implies.

The one trial everyone cites

The study, published in 2015, randomised people with androgenetic alopecia into two groups of 50, one applying rosemary oil and the other 2% minoxidil, and followed them for six months [s1]. Neither group changed much at first: there was no significant change in mean hair count at the three-month mark in either arm [s1]. By six months both groups showed a significant increase in hair count against their own baseline and against the three-month reading [s1]. Crucially, there was no significant difference between the two groups in hair count at either month three or month six [s1].

That is the finding the internet compressed into "rosemary works as well as minoxidil." The compression drops two things. First, the comparator was 2% minoxidil, the lower of the two strengths — topical minoxidil is sold over the counter in the United States at both 2% and 5%, with the 5% foam the more effective option for most people [s2]. Matching 2% minoxidil is a weaker claim than matching minoxidil in general. Second, a single trial of 100 people is a starting point, not a verdict; nothing has replicated it at the scale that would settle whether the effect is real and how large it is.

The itch was the clearer difference

The trial's most consistent finding was not about regrowth at all. Scalp itching increased significantly in both groups over the six months, but it was more frequent in the minoxidil group at both assessment points [s1]. If rosemary oil has a defensible selling point from this study, it is tolerability rather than superior efficacy — a gentler side-effect profile at a broadly similar result.

Why one trial is not enough

Rosemary oil is one of a cluster of topical hair-loss remedies — alongside rice water, onion juice and garlic gel — popularised through short-form video and since examined against the published evidence in the dermatology literature [s3]. What that examination has to work with, in rosemary's case, is the study described above: one small trial, not yet confirmed, carrying the weight of a viral claim.

The same trial checked several other scalp complaints and found nothing moving. Dry hair, greasy hair and dandruff showed no significant change from baseline in either the rosemary or the minoxidil group over the six months [s1]. Whatever rosemary oil is doing, the trial did not detect a broader effect on scalp condition beyond the shared, gradual rise in hair count.

None of that makes rosemary oil useless. The trial is real, the direction of effect was positive, and the ingredient did not underperform its comparator. But "did not differ from 2% minoxidil in one 100-person study" is a much narrower statement than the marketing, and it says nothing about how rosemary oil would fare against 5% minoxidil, against finasteride, or over the years that androgenetic alopecia actually runs. The honest position is that rosemary oil has a single encouraging trial and no confirmation, while topical minoxidil has decades of regulated use and a far larger evidence base behind its over-the-counter approval [s2].

This article is informational and is not medical advice. Androgenetic alopecia is progressive, and decisions about treating it belong with a clinician who can weigh the options against an individual's pattern of loss.

Sources

Sources

  1. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial — Skinmed , February 1, 2015
  2. Drugs@FDA: topical minoxidil product listings and marketing status — US Food and Drug Administration (openFDA) , September 1, 2026
  3. The Evidence Behind Topical Hair Loss Remedies on TikTok — Cutis , February 1, 2023

More on

Related coverage